Product NDC: | 50268-565 |
Proprietary Name: | MIDODRINE HYDROCHLORIDE |
Non Proprietary Name: | MIDODRINE HYDROCHLORIDE |
Active Ingredient(s): | 5 mg/1 & nbsp; MIDODRINE HYDROCHLORIDE |
Administration Route(s): | ORAL |
Dosage Form(s): | TABLET |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 50268-565 |
Labeler Name: | AvPAK |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | ANDA076449 |
Marketing Category: | ANDA |
Start Marketing Date: | 20110817 |
Package NDC: | 50268-565-15 |
Package Description: | 50 TABLET in 1 BOX, UNIT-DOSE (50268-565-15) |
NDC Code | 50268-565-15 |
Proprietary Name | MIDODRINE HYDROCHLORIDE |
Package Description | 50 TABLET in 1 BOX, UNIT-DOSE (50268-565-15) |
Product NDC | 50268-565 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | MIDODRINE HYDROCHLORIDE |
Dosage Form Name | TABLET |
Route Name | ORAL |
Start Marketing Date | 20110817 |
Marketing Category Name | ANDA |
Labeler Name | AvPAK |
Substance Name | MIDODRINE HYDROCHLORIDE |
Strength Number | 5 |
Strength Unit | mg/1 |
Pharmaceutical Classes | Adrenergic alpha-Agonists [MoA],alpha-Adrenergic Agonist [EPC] |